BCL6 and diffuse large B-cell lymphoma: In a recent study to suppress diffuse large B-cell lymphoma (DLBCL) progression, researchers engineered iRGD-modified exosomes to deliver B-cell lymphoma 6 (BCL6) siRNA to knock down BCL6.